Feedback / Questions
Undisclosed GPCR-targeted Peptide-drug Conjugate - Decoy Therapeutics
deuterated S-avadomide (SP-3164) - Salarius
https://www.globenewswire.com/news-release/2025/07/14/3114749/0/en/Salarius-Pharmaceuticals-Granted-Additional-Extension-to-Regain-Compliance-with-Nasdaq-s-Stockholders-Equity-Standard.html
 
Jul 14, 2025
 
SHARE THIS
  • Print
  • Email
  • More sharing
    Reddit
    StumbleUpon
    Delicious